144 related articles for article (PubMed ID: 33666284)
1. Synthesis and docking calculations of tetrafluoronaphthalene derivatives and their inhibition profiles against some metabolic enzymes.
Erdoğan M; Taslimi P; Tuzun B
Arch Pharm (Weinheim); 2021 Jun; 354(6):e2000409. PubMed ID: 33666284
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, characterization, inhibition effects, and molecular docking studies as acetylcholinesterase, α-glycosidase, and carbonic anhydrase inhibitors of novel benzenesulfonamides incorporating 1,3,5-triazine structural motifs.
Lolak N; Akocak S; Türkeş C; Taslimi P; Işık M; Beydemir Ş; Gülçin İ; Durgun M
Bioorg Chem; 2020 Jul; 100():103897. PubMed ID: 32413628
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, biological activity and docking calculations of bis-naphthoquinone derivatives from Lawsone.
Riaz MT; Yaqub M; Shafiq Z; Ashraf A; Khalid M; Taslimi P; Tas R; Tuzun B; Gulçin İ
Bioorg Chem; 2021 Sep; 114():105069. PubMed ID: 34134033
[TBL] [Abstract][Full Text] [Related]
4. In vitro inhibitory effects of some acetophenone derivatives on some metabolic enzymes and molecular docking.
Taslimi P
Arch Pharm (Weinheim); 2020 Nov; 353(11):e2000210. PubMed ID: 32876951
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, characterization, biological evaluation, and in silico studies of novel 1,3-diaryltriazene-substituted sulfathiazole derivatives.
Işık M; Akocak S; Lolak N; Taslimi P; Türkeş C; Gülçin İ; Durgun M; Beydemir Ş
Arch Pharm (Weinheim); 2020 Sep; 353(9):e2000102. PubMed ID: 32529657
[TBL] [Abstract][Full Text] [Related]
6. Pyridine sulfonamide as a small key organic molecule for the potential treatment of type-II diabetes mellitus and Alzheimer's disease: In vitro studies against yeast α-glucosidase, acetylcholinesterase and butyrylcholinesterase.
Riaz S; Khan IU; Bajda M; Ashraf M; Qurat-Ul-Ain ; Shaukat A; Rehman TU; Mutahir S; Hussain S; Mustafa G; Yar M
Bioorg Chem; 2015 Dec; 63():64-71. PubMed ID: 26451651
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, bioactivity and binding energy calculations of novel 3-ethoxysalicylaldehyde based thiosemicarbazone derivatives.
Ishaq M; Taslimi P; Shafiq Z; Khan S; Ekhteiari Salmas R; Zangeneh MM; Saeed A; Zangeneh A; Sadeghian N; Asari A; Mohamad H
Bioorg Chem; 2020 Jul; 100():103924. PubMed ID: 32442818
[TBL] [Abstract][Full Text] [Related]
8. The green synthesis and molecular docking of novel N-substituted rhodanines as effective inhibitors for carbonic anhydrase and acetylcholinesterase enzymes.
Bayindir S; Caglayan C; Karaman M; Gülcin İ
Bioorg Chem; 2019 Sep; 90():103096. PubMed ID: 31284100
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and in silico studies of triazene-substituted sulfamerazine derivatives as acetylcholinesterase and carbonic anhydrases inhibitors.
Bilginer S; Gul HI; Anil B; Demir Y; Gulcin I
Arch Pharm (Weinheim); 2021 Jan; 354(1):e2000243. PubMed ID: 32984993
[TBL] [Abstract][Full Text] [Related]
10. Biology-oriented drug synthesis and evaluation of secnidazole esters as novel enzyme ınhibitors.
Ansari MA; Saad SM; Khan KM; Salar U; Taslimi P; Taskın-Tok T; Saleem F; Jahangir S
Arch Pharm (Weinheim); 2022 Feb; 355(2):e2100376. PubMed ID: 34862640
[TBL] [Abstract][Full Text] [Related]
11. Exploring fluorine-substituted piperidines as potential therapeutics for diabetes mellitus and Alzheimer's diseases.
Mughal EU; Hawsawi MB; Naeem N; Hassan A; Alluhaibi MS; Ali Shah SW; Nazir Y; Sadiq A; Alrafai HA; Ahmed SA
Eur J Med Chem; 2024 Jul; 273():116523. PubMed ID: 38795518
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, biological evaluation and molecular docking of novel pyrazole derivatives as potent carbonic anhydrase and acetylcholinesterase inhibitors.
Turkan F; Cetin A; Taslimi P; Karaman M; Gulçin İ
Bioorg Chem; 2019 May; 86():420-427. PubMed ID: 30769267
[TBL] [Abstract][Full Text] [Related]
13. Sulfonamides incorporating ketene N,S-acetal bioisosteres as potent carbonic anhydrase and acetylcholinesterase inhibitors.
Istrefi Q; Türkeş C; Arslan M; Demir Y; Nixha AR; Beydemir Ş; Küfrevioğlu ÖI
Arch Pharm (Weinheim); 2020 Jun; 353(6):e1900383. PubMed ID: 32285537
[TBL] [Abstract][Full Text] [Related]
14. New quinoxalin-1,3,4-oxadiazole derivatives: Synthesis, characterization, in vitro biological evaluations, and molecular modeling studies.
Mirzazadeh R; Asgari MS; Barzegari E; Pedrood K; Mohammadi-Khanaposhtani M; Sherafati M; Larijani B; Rastegar H; Rahmani H; Mahdavi M; Taslimi P; Üç EM; Gulçin İ
Arch Pharm (Weinheim); 2021 Sep; 354(9):e2000471. PubMed ID: 33999440
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, characterization, molecular docking and biological activities of novel pyrazoline derivatives.
Turkan F; Cetin A; Taslimi P; Karaman HS; Gulçin İ
Arch Pharm (Weinheim); 2019 Jun; 352(6):e1800359. PubMed ID: 31125504
[TBL] [Abstract][Full Text] [Related]
16. Novel propanolamine derivatives attached to 2-metoxifenol moiety: Synthesis, characterization, biological properties, and molecular docking studies.
Genc Bilgicli H; Ergon D; Taslimi P; Tüzün B; Akyazı Kuru İ; Zengin M; Gülçin İ
Bioorg Chem; 2020 Aug; 101():103969. PubMed ID: 32474181
[TBL] [Abstract][Full Text] [Related]
17. Acetylcholinesterase and carbonic anhydrase inhibitory properties of novel urea and sulfamide derivatives incorporating dopaminergic 2-aminotetralin scaffolds.
Özgeriş B; Göksu S; Polat Köse L; Gülçin İ; Salmas RE; Durdagi S; Tümer F; Supuran CT
Bioorg Med Chem; 2016 May; 24(10):2318-29. PubMed ID: 27068142
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, molecular docking, and biological activities of new cyanopyridine derivatives containing phenylurea.
Gezegen H; Gürdere MB; Dinçer A; Özbek O; Koçyiğit ÜM; Taslimi P; Tüzün B; Budak Y; Ceylan M
Arch Pharm (Weinheim); 2021 Apr; 354(4):e2000334. PubMed ID: 33300644
[TBL] [Abstract][Full Text] [Related]
19. Novel 2-methylimidazolium salts: Synthesis, characterization, molecular docking, and carbonic anhydrase and acetylcholinesterase inhibitory properties.
Bal S; Kaya R; Gök Y; Taslimi P; Aktaş A; Karaman M; Gülçin İ
Bioorg Chem; 2020 Jan; 94():103468. PubMed ID: 31791684
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, molecular docking, and some metabolic enzyme inhibition properties of novel quinazolinone derivatives.
Tokalı FS; Taslimi P; Demircioğlu İH; Karaman M; Gültekin MS; Şendil K; Gülçin İ
Arch Pharm (Weinheim); 2021 May; 354(5):e2000455. PubMed ID: 33537994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]